Skip to main content
Clinical Trials/CTRI/2022/12/047816
CTRI/2022/12/047816Recruiting未知

A comparative study to evaluate the safety & efficacy of Etoricoxib and Piroxicam in pharmacotherapy of Osteoarthritis in tertiary care hospital Kanpurâ??â??

PRINC BGHEA0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Patients with symptomatic osteoarthritis of age 35 to 65 years who fulfill the western Ontario and McMaster universities osteoarthritis index (WOMAC)
  • 2. Criterion for the diagnosis of osteoarthritis will be enrolled.
  • 3. Patients having symptomatic Osteoarthritis either as a new case or as an old case following discontinuation of treatment with NSAIDS or other analgesic medications with a washout period of one week
  • 4. All these patients will be examined as per the baseline criteria will be included in the study if they fit this criterion.

Exclusion Criteria

  • 1. Smokers/ alcoholics
  • 2. Pregnant & lactating women.
  • 3. Patients on steroid therapy, history of chronic infections like TB, leprosy, recent trauma, surgery, mental retardation, minor.
  • 4. Patients with liver diseases, kidney diseases, and cardiac problems.

Investigators

Sponsor
PRINC BGHEA

Similar Trials